• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利什曼原虫无鞭毛体上调基因在三种不同形式利什曼病中的体内表达比较

Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis.

作者信息

Sharma Paresh, Gurumurthy Srividya, Duncan Robert, Nakhasi Hira L, Salotra Poonam

机构信息

Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India.

出版信息

Parasitol Int. 2010 Jun;59(2):262-4. doi: 10.1016/j.parint.2009.11.003. Epub 2009 Dec 4.

DOI:10.1016/j.parint.2009.11.003
PMID:19963076
Abstract

In Old World Leishmania infections in India, Leishmania donovani is responsible for visceral leishmaniasis (VL) and post kala-azar dermal leishmaniasis (PKDL) while L. tropica is responsible for cutaneous leishmaniasis (CL) in humans. The molecular differences between the two species of Leishmania and within the same species causing distinct pathologies that govern the outcome of infection and pathogenesis in the human host are unknown. Quantitative expression of selected genes was evaluated directly in lesion tissues of VL, PKDL and CL patients. Assessment of in vivo mRNA level highlighted substantial differences in gene expression patterns, providing an indication of the genes involved in pathogenesis in the three different forms of Leishmaniasis.

摘要

在印度的旧大陆利什曼原虫感染中,杜氏利什曼原虫导致内脏利什曼病(VL)和黑热病后皮肤利什曼病(PKDL),而热带利什曼原虫导致人类皮肤利什曼病(CL)。导致不同病理状况、决定人类宿主感染结果和发病机制的两种利什曼原虫之间以及同一物种内的分子差异尚不清楚。直接在VL、PKDL和CL患者的病变组织中评估了选定基因的定量表达。对体内mRNA水平的评估突出了基因表达模式的显著差异,这表明了三种不同形式利什曼病发病机制中涉及的基因。

相似文献

1
Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis.利什曼原虫无鞭毛体上调基因在三种不同形式利什曼病中的体内表达比较
Parasitol Int. 2010 Jun;59(2):262-4. doi: 10.1016/j.parint.2009.11.003. Epub 2009 Dec 4.
2
Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.印度东部内脏利什曼病和黑热病后皮肤利什曼病菌株之间的遗传异质性。
Infect Genet Evol. 2007 Mar;7(2):219-22. doi: 10.1016/j.meegid.2006.09.001. Epub 2006 Oct 5.
3
Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.来自印度黑热病后皮肤利什曼病患者的杜氏利什曼原虫分离株的基因指纹分析及差异表达基因的鉴定
Parasitology. 2008 Jan;135(Pt 1):23-32. doi: 10.1017/S0031182007003484. Epub 2007 Aug 28.
4
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.评估来自印度的对锑敏感和耐药的利什曼原虫临床分离株中的水甘油通道蛋白基因状态和表达谱。
J Antimicrob Chemother. 2010 Mar;65(3):496-507. doi: 10.1093/jac/dkp468. Epub 2010 Jan 12.
5
Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.开发一种用于检测黑热病和黑热病后皮肤利什曼病患者临床样本中杜氏利什曼原虫的种特异性聚合酶链反应检测方法。
J Clin Microbiol. 2001 Mar;39(3):849-54. doi: 10.1128/JCM.39.3.849-854.2001.
6
A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.在接受高效抗逆转录病毒治疗的埃塞俄比亚艾滋病毒阳性患者中,出现了一种具有 ITS1 序列多态性的利什曼原虫临床分离株,这是引起副皮肤利什曼病的原因。
Br J Dermatol. 2010 Oct;163(4):870-4. doi: 10.1111/j.1365-2133.2010.09768.x.
7
Amplified fragment length polymorphism (AFLP) analysis is useful for distinguishing Leishmania species of visceral and cutaneous forms.扩增片段长度多态性 (AFLP) 分析可用于区分内脏和皮肤形式的利什曼原虫物种。
Acta Trop. 2010 Feb;113(2):202-6. doi: 10.1016/j.actatropica.2009.10.006. Epub 2009 Oct 23.
8
Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis.从黑热病后皮肤利什曼病患者分离出的杜氏利什曼原虫表面蛋白的上调。
Microbes Infect. 2006 Mar;8(3):637-44. doi: 10.1016/j.micinf.2005.08.018. Epub 2006 Jan 11.
9
Leishmaniasis in Turkey: molecular characterization of Leishmania from human and canine clinical samples.土耳其的利什曼病:来自人类和犬类临床样本的利什曼原虫分子特征
Trop Med Int Health. 2009 Nov;14(11):1401-6. doi: 10.1111/j.1365-3156.2009.02384.x. Epub 2009 Sep 7.
10
Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.利用重组蛋白 K39 诊断尼泊尔黑热病后皮肤利什曼病
Southeast Asian J Trop Med Public Health. 2007 Jul;38(4):619-25.

引用本文的文献

1
Quantitative monitoring of experimental and human leishmaniasis employing amastigote-specific genes.采用无鞭毛体特异性基因对实验性和人体利什曼病进行定量监测。
Parasitology. 2022 Jul;149(8):1085-1093. doi: 10.1017/S0031182022000610. Epub 2022 May 10.
2
An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient.来自卡拉-阿瑟氏病后皮肤利什曼病(PKDL)患者的利什曼原虫 Donovan 株的深入蛋白质组图谱。
Acta Parasitol. 2022 Jun;67(2):687-696. doi: 10.1007/s11686-021-00511-3. Epub 2022 Jan 12.
3
Protective or Detrimental? Understanding the Role of Host Immunity in Leishmaniasis.
保护还是有害?了解宿主免疫在利什曼病中的作用。
Microorganisms. 2019 Dec 13;7(12):695. doi: 10.3390/microorganisms7120695.
4
A Leishmania-specific gene upregulated at the amastigote stage is crucial for parasite survival.一种在无鞭毛体阶段上调的利什曼原虫特异性基因对寄生虫的存活至关重要。
Parasitol Res. 2018 Oct;117(10):3215-3228. doi: 10.1007/s00436-018-6020-6. Epub 2018 Aug 14.
5
Determinants for the development of visceral leishmaniasis disease.内脏利什曼病发病的决定因素。
PLoS Pathog. 2013 Jan;9(1):e1003053. doi: 10.1371/journal.ppat.1003053. Epub 2013 Jan 3.
6
Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex.全基因组 SNP 和微卫星变异揭示利什曼原虫复合种的人群水平流行病学。
Infect Genet Evol. 2012 Jan;12(1):149-59. doi: 10.1016/j.meegid.2011.11.005. Epub 2011 Nov 20.